diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar Hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
While hyperosmolar Hyperglycemic state in pediatric patients have blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Evaluation

Diagnostic Criteria for diabetic ketoacidosis (DKA)

  • Blood glucose >13.9 mmol/L (>250 mg/dL)
  • Arterial pH <7.3 in adults or venous pH <7.3 in pediatrics
  • Bicarbonate <15 mEq/L
  • Moderate ketonuria or ketonemia
  • Anion gap >12

Diagnostic Criteria for hyperosmolar hyperglycemic state (HHS) in Adults

  • Blood glucose >33.3 mmol/L (>600 mg/dL)
  • Arterial pH >7.3
  • Bicarbonate >15 mEq/L
  • Mild ketonuria or ketonemia
  • Effective serum osmolality >320 mOsm/kg
  • Anion gap variable

Diagnostic Criteria for HHS in Pediatrics

  • Blood glucose >33.3 mmol/L (>600 mg/dL)
  • Venous pH >7.3
  • Bicarbonate >15 mEq/L
  • Altered mental status or severe dehydration

History

  • History of polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain (in DKA)
  • Dehydration
  • Weakness

Physical Examination

  • Altered mental status or sensoria clouding to coma (more frequent in HHS)
  • Poor skin turgor, dry axilla & oral mucosa, Kussmaul respirations (in DKA), low jugular venous pressure, tachycardia, hypotension, shock

Laboratory Tests

  • Serum glucose
  • Blood urea nitrogen (BUN)/creatinine
  • Serum ketones
  • Electrolytes (anion gap)
  • Serum osmolality
    • Effective osmolality = (2 × Na) + (glucose/18) 
  • Urinalysis
  • ECG &/or chest X-ray (CXR), if indicated
  • Urine ketones by dipstick
  • Arterial blood gas
  • CBC w/ differential
  • Urine, blood & throat culture
  • Glycosylated hemoglobin (HbA1c)
  • Nitroprusside testing
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Among patients with rheumatoid arthritis, those who are obese are more likely to have worse disease activity, lower functional ability and poorer health-related quality of life compared with their nonobese counterparts, a study has found.
Pearl Toh, 13 Apr 2018
Impaired endothelial-dependent microvascular reactivity appears to be predictive of albuminuria progression in Asian patients with type 2 diabetes (T2D) who have normal urine albumin levels at baseline, but not in those with microalbuminuria, a prospective longitudinal cohort study suggests.
30 May 2016
Good glycaemic control and minimizing CV risk factors are the cornerstones of T2D management. Empagliflozin, a SGLT2 inhibitor, has a unique mechanism of action that not only lowers plasma glucose but also other CV risk factors. The EMPA-REG OUTCOME® trial explored the CV benefits of this drug, and a panel of eminent speakers gathered recently to present the implications of this study and empagliflozin on clinical practice.
Stephen Padilla, 13 Apr 2018
The use of dipeptidyl peptidase-4 inhibitors may heighten the risk of inflammatory bowel disease (IBD) in patients with type 2 diabetes (T2D), according to a recent study.